VIRBAC SA | 165,77 Euro | +0,300 +0,18 % | |
| WKN: 874929 ISIN: FR0000031577 Ticker-Symbol: V16 | Stuttgart | 21.05.13 | 08:07 Uhr |
Branche PharmaAktienmarkt CAC Mid 60 |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 25.06. | XFRA DIVIDEND INFORMATION - 26.06.2012 - 1 | 217 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 25.06.2012 CUM DIVIDENDE UND AM 26.06.2012
EX DIVIDENDE GEHANDELT.
THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 25.06.2012. THE
EX-DIVIDEND DAY WILL BE 26.06.2012.
... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 26.06.2012 - 1 | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| GUERBET | 95,27 | -0,16 % | Medical Imaging Drugs Advisory Committee Recommends Approval of Guerbet NDA for Dotarem (gadoterate meglumine) |
| PHARMAXIS | 0,142 | +35,24 % | PHARMAXIS LTD: Pharmaxis Agrees Key Cystic Fibrosis Trial Paramaters with F |
| GRIFOLS | 28,586 | -1,44 % | Grifols signs deal to license Aradigm's Pulmaquin |
| IPSEN | 27,136 | -0,16 % | Ipsen : Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company |
| BOIRON | 40,768 | -0,81 % | BOIRON: 2013 first quarter activity |
